1. According to findings from the 2009-2010 National Health and Nutrition Examination Survey (NHANES), the prevalence of periodontal disease for adults aged 30 years and older is approximately
A. 25%
B. 30%
C. 50%
D. 75%
2. Common bacteria found in dental biofilm include which of the following:
A. Streptococcus mutans
B. Streptococcus sanguis
C. Porphyromonas gingivalis
D. All of the above
3. With regard to oral disease and its impact on systemic health, which of the following statements is NOT correct:
A. Studies suggest that patients with severe periodontal disease are at increased risk of stroke
B. Studies suggest that the relationship between diabetes and periodontal disease is bidirectional
C. Studies have identified proof of a causative link between periodontal disease and cardiovascular disease
D. None of the above
4. A therapeutic ingredient in an over-the-counter (OTC) mouth rinse product that the U.S. Food and Drug Administration (FDA) has deemed safe and effective for human use is recognized as which of the following:
A. Category 1
B. Category 2
C. Category 3
D. Category 4
5. All of the following statements are correct regarding the American Dental Association's (ADA) Seal of Acceptance program EXCEPT:
A. Product efficacy must be demonstrated through at least 2 independent, placebo-controlled trials that are at minimum 6 months in duration
B. The ADA Seal program is mandatory
C. The ADA Seal program includes both safety and efficacy evaluations of ALL mouth rinse products that bear its label
D. None of the above
6. Cosmetic mouth rinse products
A. Do not prevent gingivitis
B. Do not prevent dental caries
C. Do not reduce plaque
D. All of the above
7. Which one of the following mouth rinse ingredients is considered the gold standard for the reduction/prevention of plaque-induced gingivitis:
A. Chlorhexidine gluconate
B. Essential oils (EOs)
C. Cetylpyridinium chloride CPC
D. Delmopinol
8. The therapeutic activity of CPC is dependent upon which of the following:
A. The positioning of a cetyl radical within its medicinal structure
B. The concentration of drug
C. The percentage of drug that is biologically active
D. All of the above
9. All of the following statements regarding delmopinol are correct EXCEPT:
A. Delmopinol is a class 2 medical device
B. Delmopinol has little or no effects on bacterial growth
C. Delmopinol exhibits less tooth staining than chlorhexidine
D. Delmopinol has a high alcohol content
10. In which of the following patient populations is an alcohol-free mouth rinse likely to improve patient acceptance:
A. Patients with oral ulcerations
B. Patients with xerostomia
C. Patients who are recovering alcoholics
D. All of the above
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Will the information presented cause you to change your practice?
A. Yes
B. No
24. Are you committed to making these changes?
A. Yes
B. No
25. As a result of this activity, did you learn something new?
A. Yes
B. No
26. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology/Specialty Pharmacy
I. Industry/Manufacturing
27. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
